A Review of Modern Radiation Therapy Dose Escalation in Locally Advanced Head and Neck Cancer
| Autor: | Dinesh Vignarajah, Myo Min, Daisy Atwell, K. Cahill, Jim Lagopoulos, N. Hearn, J. Elks |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Chemotherapy
medicine.medical_specialty Modalities business.industry Radiotherapy Planning Computer-Assisted medicine.medical_treatment Head and neck cancer Cancer medicine.disease 030218 nuclear medicine & medical imaging Radiation therapy Functional imaging 03 medical and health sciences 0302 clinical medicine Oncology Head and Neck Neoplasms 030220 oncology & carcinogenesis Cohort medicine Dose escalation Humans Radiology Nuclear Medicine and imaging Dose Fractionation Radiation Radiology business |
| Zdroj: | Clinical Oncology. 32:330-341 |
| ISSN: | 0936-6555 |
| Popis: | The management of head and neck cancer is complex and often involves multimodality treatment. Certain groups of patients, such as those with inoperable or advanced disease, are at higher risk of treatment failure and may therefore benefit from radiation therapy dose escalation. This can be difficult to achieve without increasing toxicity. However, the combination of modern treatment techniques and increased research into the use of functional imaging modalities that assist with target delineation allows researchers to push this boundary further. This review aims to summarise modern dose escalation trials to identify the impact on disease outcomes and explore the growing role of functional imaging modalities. Studies experimenting with dose escalation above standard fractionated regimens as outlined in National Comprehensive Cancer Network guidelines using photon therapy were chosen for review. Seventeen papers were considered suitable for inclusion in the review. Eight studies investigated nasopharyngeal cancer, with the remainder treating a range of subsites. Six studies utilised functional imaging modalities for target delineation. Doses as high as 85.9 Gy in 2.6 Gy fractions (EQD2 90.2 Gy10) were reportedly delivered with the aid of functional imaging modalities. Dose escalation in nasopharyngeal cancer resulted in 3-year locoregional control rates of 86.6-100% and overall survival of 82-95.2%. For other mucosal primary tumour sites, 3-year locoregional control reached 68.2-85.9% and 48.4-54% for overall survival. There were no clear trends in acute or late toxicity across studies, regardless of dose or addition of chemotherapy. However, small cohort sizes and short follow-up times may have resulted in under-reporting. This review highlights the future possibilities of radiation therapy dose escalation in head and neck cancer and the potential for improved target delineation with careful patient selection and the assistance of functional imaging modalities. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect